Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor version bump and does not alter study content or critical functionality.
    Difference
    0.1%
    Check dated 2026-01-14T01:58:54.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Update added in Study Record: last known status and updater (Wilson Miller, Jewish General Hospital) with date 2021-02 and verification status.
    Difference
    0.4%
    Check dated 2026-01-06T22:51:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now includes a Locations section with a Quebec site; the Quebec Locations entry and the HHS Vulnerability Disclosure link were removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:39:59.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Results status updated from No Results Posted to Results Submitted; page revision updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T20:52:49.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    General funding/operating status banner about potential data delays has been removed from the page. This removal does not affect the study details, eligibility criteria, or reported results.
    Difference
    0.4%
    Check dated 2025-11-17T18:14:02.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant modifications to the study details page were observed; differences appear limited to layout or presentation elements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:48:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.